1932

Abstract

Omega-3 polyunsaturated fatty acids (PUFAs) include α-linolenic acid (ALA; 18:3 ω-3), stearidonic acid (SDA; 18:4 ω-3), eicosapentaenoic acid (EPA; 20:5 ω-3), docosapentaenoic acid (DPA; 22:5 ω-3), and docosahexaenoic acid (DHA; 22:6 ω-3). In the past few decades, many epidemiological studies have been conducted on the myriad health benefits of omega-3 PUFAs. In this review, we summarized the structural features, properties, dietary sources, metabolism, and bioavailability of omega-3 PUFAs and their effects on cardiovascular disease, diabetes, cancer, Alzheimer's disease, dementia, depression, visual and neurological development, and maternal and child health. Even though many health benefits of omega-3 PUFAs have been reported in the literature, there are also some controversies about their efficacy and certain benefits to human health.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-food-111317-095850
2018-03-25
2024-05-27
Loading full text...

Full text loading...

/deliver/fulltext/food/9/1/annurev-food-111317-095850.html?itemId=/content/journals/10.1146/annurev-food-111317-095850&mimeType=html&fmt=ahah

Literature Cited

  1. Ackman RG. 2005. Fish oils. Bailey's Industrial Oil and Fat Products 3 F Shahidi 279–317 Hoboken, NJ: Wiley [Google Scholar]
  2. Alasalvar C, Shahidi F, Quantick P. 2002. Food and health applications of marine nutraceuticals: a review. Seafoods: Quality, Technology and Nutraceutical Applications C Alasalvar, T Taylor 175–204 Heidelberg, Ger: Springer [Google Scholar]
  3. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ. et al. 1998. Fish consumption and risk of sudden cardiac death. J. Am. Med. Assoc 279:23–28 [Google Scholar]
  4. Arnold LE, Young AS, Belury MA, Cole RM, Gracious B. et al. 2017. Omega-3 fatty acid plasma levels before and after supplementation: correlations with mood and clinical outcomes in the omega-3 and therapy studies. J. Child Adolesc. Psychopharmacol. 27:223–33 [Google Scholar]
  5. Arts MT, Ackman RG, Holub BJ. 2001. Essential fatty acids in aquatic ecosystems: a crucial link between diet and human health and evolution. Can. J. Fish. Aquat. Sci. 58:122–37 [Google Scholar]
  6. Aursand M, Bleivik B, Rainuzzo JR, Leif J, Mohr V. 1994. Lipid distribution and composition of commercially farmed Atlantic salmon (Salmo salar). J. Sci. Food Agric. 64:239–48 [Google Scholar]
  7. Balstad TR, Pettersen CH, Laird B, Fearon K, Schønberg SMA. et al. 2015. MON-PP096: changes in plasma levels of omega-3 PUFAs in response to supplementation with omega-3 PUFA-enriched oral nutritional supplements in advanced cancer patients. Clin. Nutr. 34:S163 [Google Scholar]
  8. Bang HO, Dyerberg J, Sinclair HM. 1980. The composition of the Eskimo food in north western Greenland. Am. J. Clin. Nutr. 33:2657–61 [Google Scholar]
  9. Barberger-Gateau P, Letenneur L, Deschamps V, Pérès K, Dartigues JF, Renaud S. 2002. Fish, meat, and risk of dementia: cohort study. BMJ 325:932–33 [Google Scholar]
  10. Barnés CM, Prox D, Christison-Lagay EA, Le HD, Short S. et al. 2011. Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib. Pediatr. Res. 71:168–78 [Google Scholar]
  11. Beckermann B, Beneke M, Seitz I. 1990. Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers. Arzneimittel-Forschung 40:700–4 [Google Scholar]
  12. Belin RJ, Greenland P, Martin L, Oberman A, Tinker L. et al. 2011. Fish intake and the risk of incident heart failure: the women's health initiative. Circ. Heart Fail. 4:404–13 [Google Scholar]
  13. Berquin IM, Min Y, Wu R, Wu J, Perry D. et al. 2007. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J. Clin. Investig. 117:1866–75 [Google Scholar]
  14. Best KP, Gold M, Kennedy D, Martin J, Makrides M. 2016. Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials. Am. J. Clin. Nutr. 103:128–43 [Google Scholar]
  15. Bimbo AP. 1990. Production of fish oil. Fish Oils in Nutrition ME Stansby 141–80 New York: Van Nostrand Reinhold [Google Scholar]
  16. Block ER, Edwards D. 1987. Effect of plasma membrane fluidity on serotonin transport by endothelial cells. Am. J. Physiol. Cell Physiol. 253:C672–78 [Google Scholar]
  17. Boudrault C, Bazinet RP, Ma DW. 2009. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J. Nutr. Biochem. 20:1–10 [Google Scholar]
  18. Budge SM, Iverson SJ, Bowen WD, Ackman RG. 2002. Among- and within-species variability in fatty acid signatures of marine fish and invertebrates on the Scotian Shelf, Georges Bank, and southern Gulf of St. Lawrence. Can. J. Fish. Aquat. Sci. 59:886–98 [Google Scholar]
  19. Burdge GC, Wootton SA. 2002. Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 88:411–20 [Google Scholar]
  20. Burdge GC, Calder PC. 2005. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod. Nutr. Dev. 45:581–97 [Google Scholar]
  21. Burr ML, Gilbert JF, Holliday RA, Elwood PC, Fehily AM. et al. 1989. Effects of changes in fat, fish, and fiber intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 334:757–61 [Google Scholar]
  22. Calder PC. 2006. Polyunsaturated fatty acids and inflammation. Prostaglandin Leukot. Essent. Fatty Acids 75:197–202 [Google Scholar]
  23. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. 2006. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin. Chem. 52:2265–72 [Google Scholar]
  24. Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D. et al. 2013. DHA supplementation and pregnancy outcomes. Am. J. Clin. Nutr. 97:808–15 [Google Scholar]
  25. Carney RM, Steinmeyer BC, Freedland KE, Rubin EH, Rich MW, Harris WS. 2016. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements. J. Clin. Psychiatry 77:e138–43 [Google Scholar]
  26. Catena A, Muñoz-Machicao JA, Torres-Espínola FJ, Martínez-Zaldívar C, Diaz-Piedra C. et al. 2016. Folate and long-chain polyunsaturated fatty acid supplementation during pregnancy has long-term effects on the attention system of 8.5-y-old offspring: a randomized controlled trial. Am. J. Clin. Nutr. 103:1115–27 [Google Scholar]
  27. Caygill CPJ, Charlett A, Hill MJ. 1996. Fat, fish, fish oil and cancer. Br. J. Cancer 74:159–64 [Google Scholar]
  28. Cederholm T. 2017. Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults: any news?. Curr. Opin. Clin. Nutr. Metab. Care 20:104–9 [Google Scholar]
  29. Chen J, Stavro PM, Thompson LU. 2002. Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr. Cancer 43:187–92 [Google Scholar]
  30. Chen YQ, Edwards IJ, Kridel SJ, Thornburg T, Berquin IM. 2007. Dietary fat-gene interactions in cancer. Cancer Metastasis Rev 26:535–51 [Google Scholar]
  31. Chin JP, Gust AP, Nestel PJ, Dart AM. 1993. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 21:22–28 [Google Scholar]
  32. Clandinin MT, Chappell JE, Heim T, Swyer PR, Chance GW. 1981. Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum. Dev. 5:355–66 [Google Scholar]
  33. Cole GM, Ma QL, Frautschy SA. 2009. Omega-3 fatty acids and dementia. Prostaglandin Leukot. Essent. Fatty Acids 81:213–21 [Google Scholar]
  34. Colussi G, Catena C, Novello M, Bertin N, Sechi LA. 2017. Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes. Nutr. Metab. Cardiovasc. Dis. 27:191–200 [Google Scholar]
  35. Connor WE. 2000. Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71:171S–75 [Google Scholar]
  36. Cook CM, Hallaråker H, Sæbø PC, Innis SM, Kelley KM. et al. 2016. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols. Prostaglandin Leukot. Essent. Fatty Acids 111:17–24 [Google Scholar]
  37. Copeman LA, Parrish CC. 2004. Lipids classes, fatty acids, and sterols in seafood from Gilbert Bay, Southern Labrador. J. Agric. Food Chem. 52:4872–81 [Google Scholar]
  38. Cottin SC, Alsaleh A, Sanders TAB, Hall WL. 2016. Lack of effect of supplementation with EPA or DHA on platelet-monocyte aggregates and vascular function in healthy men. Nutr. Metab. Cardiovasc. Dis. 26:743–51 [Google Scholar]
  39. Courville AB, Harel O, Lammi-Keefe CJ. 2011. Consumption of a DHA-containing functional food during pregnancy is associated with lower infant ponderal index and cord plasma insulin concentration. Br. J. Nutr. 106:208–12 [Google Scholar]
  40. Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. 2009. Fish, docosahexaenoic acid and Alzheimer's disease. Prog. Lipid Res. 48:239–56 [Google Scholar]
  41. Daiello LA, Gongvatana A, Dunsiger S, Cohen RA, Ott BR, Alzheimer's Dis. Neuroimaging Initiat. 2015. Association of fish oil supplement use with preservation of brain volume and cognitive function. Alzheimer's Dement 11:226–35 [Google Scholar]
  42. Dangour AD, Allen E, Elbourne D, Fasey N, Fletcher AE. et al. 2010. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am. J. Clin. Nutr. 91:1725–32 [Google Scholar]
  43. da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss Á. et al. 2008. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J. Affect. Disord. 111:351–59 [Google Scholar]
  44. Davidson M, Bulkow LR, Gellin BG. 1993. Cardiac mortality in Alaska's indigenous and non-native residents. Int. J. Epidemiol. 22:62–71 [Google Scholar]
  45. Davidson MH, Johnson J, Rooney MW, Kyle ML, Kling DF. 2012. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study. J. Clin. Lipidol. 6:573–84 [Google Scholar]
  46. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K. et al. 1997. Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med. 336:1046–53 [Google Scholar]
  47. de Aguiar Pastore Silva J, de Souza Fabre ME, Waitzberg DL. 2015. Omega-3 supplements for patients in chemotherapy and/or radiotherapy: a systematic review. Clin. Nutr. 34:359–66 [Google Scholar]
  48. de Goede J, Geleijnse JM, Boer JM, Kromhout D, Verschuren WM. 2010. Marine (n-3) fatty acids, fish consumption, and the 10-year risk of fatal and nonfatal coronary heart disease in a large population of Dutch adults with low fish intake. J. Nutr. 140:1023–28 [Google Scholar]
  49. DeFilippis AP, Blaha MJ, Jacobson TA. 2010. Omega-3 fatty acids for cardiovascular disease prevention. Curr. Treat. Options Cardiovasc. Med. 12:365–80 [Google Scholar]
  50. Derosa G, Cicero AF, Fogari E, D'Angelo A, Bonaventura A. et al. 2012. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load. J. Clin. Lipidol. 6:553–64 [Google Scholar]
  51. Dichwalkar T, Patel S, Bapat S, Pancholi P, Jasani N. et al. 2017. Omega‐3 fatty acid grafted PAMAM‐Paclitaxel conjugate exhibits enhanced anticancer activity in upper gastrointestinal cancer cells. Macromol. Biosci. 17:1600457 [Google Scholar]
  52. Dietit. Can. 2013. Food Sources of Omega-3 Fats Toronto, Ont: Dietit. Can http://www.dietitians.ca/getattachment/de95e92c-3fb3-40db-b457-173de89bdc3a/FACTSHEET-Food-Sources-of-Omega-3-Fats.pdf.aspx
  53. Dijck-Brouwer DJ, Hadders-Algra M, Bouwstra H, Decsi T, Boehm G. et al. 2005. Lower fetal status of docosahexaenoic acid, arachidonic acid and essential fatty acids is associated with less favorable neonatal neurological condition. Prostaglandin Leukot. Essent. Fatty Acids 72:21–28 [Google Scholar]
  54. Djoussé L, Gaziano JM, Buring JE, Lee IM. 2011. Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am. J. Clin. Nutr. 93:143–50 [Google Scholar]
  55. Doornbos B, Van Goor SA, Dijck-Brouwer DAJ, Schaafsma A, Korf J, Muskiet FAJ. 2009. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 33:49–52 [Google Scholar]
  56. Dunstan JA, Simmer K, Dixon G, Prescott SL. 2008. Cognitive assessment of children at age 21/2 years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 93:F45–50 [Google Scholar]
  57. Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB. 2010. Bioavailability of marine n-3 fatty acid formulations. Prostaglandin Leukot. Essent. Fatty Acids 83:137–41 [Google Scholar]
  58. Engler MM, Engler MB, Malloy M, Chiu E, Besio D. et al. 2004. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int. J. Clin. Pharmacol. Ther. 42:672–79 [Google Scholar]
  59. Erkkilä AT, Lehto S, Pyörälä K, Uusitupa MI. 2003. n-3 fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am. J. Clin. Nutr. 78:65–71 [Google Scholar]
  60. FAO. 2010. Fats and fatty acids in human nutrition: report of an expert consultation. Rome: FAO
  61. Farooqui AA, Horrocks LA. 2001. Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue. J. Mol. Neurosci. 16:263–72 [Google Scholar]
  62. Farquharson J, Jamieson EC, Abbasi KA, Patrick WJ, Logan RW, Cockburn F. 1995. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch. Dis. Child. 72:198–203 [Google Scholar]
  63. Farshbaf-Khalili A, Mohammad-Alizadeh S, Farshbaf-Khalili A, Mohammadi F, Ostadrahimi A. 2016. Fish-oil supplementation and maternal mental health: a triple-blind, randomized controlled trial. Iran Red Crescent Med. J 19:e36327 [Google Scholar]
  64. Farsi PF, Djazayery A, Eshraghian MR, Koohdani F, Saboor-Yaraghi AA. et al. 2014. Effects of supplementation with omega-3 on insulin sensitivity and non-esterified free fatty acid (NEFA) in type 2 diabetic patients. Arq. Bras. Endocrinol. Metabol. 58:335–40 [Google Scholar]
  65. Finley JW, Shahidi F. 2001. The chemistry, processing, and health benefits of highly unsaturated fatty acids: an overview. Omega-3 Fatty Acids F Shahidi, JW Finely 2–11 Washington, DC: ACS [Google Scholar]
  66. Finocchiaro C, Segre O, Fadda M, Monge T, Scigliano M. et al. 2012. Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. Br. J. Nutr. 108:327–33 [Google Scholar]
  67. Fleith M, Clandinin MT. 2005. Dietary PUFA for preterm and term infants: review of clinical studies. Crit. Rev. Food Sci. Nutr. 45:205–29 [Google Scholar]
  68. Flower G, Fritz H, Balneaves LG, Verma S, Skidmore B. et al. 2014. Flax and breast cancer: a systematic review. Integr. Cancer Ther. 13:181–92 [Google Scholar]
  69. Fodor JG, Helis E, Yazdekhasti N, Vohnout B. 2014. “Fishing” for the origins of the “Eskimos and heart disease” story: facts or wishful thinking?. Can. J Cardiol. 30:864–68 [Google Scholar]
  70. Folsom AR, Demissie Z. 2004. Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women. Am. J. Epidemiol. 160:1005–10 [Google Scholar]
  71. Frasure-Smith N, Lespérance F, Julien P. 2004. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol. Psychiatry 55:891–96 [Google Scholar]
  72. Freeman M, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. 2006. Randomized dose‐ranging pilot trial of omega‐3 fatty acids for postpartum depression. Acta Psychiatr. Scand. 113:31–35 [Google Scholar]
  73. Garg ML, Sebokova E, Thomson AB, Clandinin MT. 1988. Δ6-Desaturase activity in liver microsomes of rats fed diets enriched with cholesterol and/or ω3 fatty acids. Biochem. J. 249:351–56 [Google Scholar]
  74. Ginty AT, Muldoon MF, Kuan DC, Schirda B, Kamarck TW. et al. 2017. Omega-3 supplementation and the neural correlates of negative affect and impulsivity: a double-blind, randomized, placebo-controlled trial in midlife adults. Psychosom. Med. 79:549–56 [Google Scholar]
  75. GISSI-Prevenzione Investig. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447–55 [Google Scholar]
  76. Glauber H, Wallace P, Griver K, Brechtel G. 1988. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann. Int. Med. 108:663–68 [Google Scholar]
  77. Gould JF, Smithers LG, Makrides M. 2013. The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 97:531–44 [Google Scholar]
  78. Gould JF, Treyvaud K, Yelland LN, Anderson PJ, Smithers LG. et al. 2017. Seven-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. J. Am. Med. Assoc 317:1173–75 [Google Scholar]
  79. Grenyer BF, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM. et al. 2007. Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31:1393–96 [Google Scholar]
  80. Griffin MD, Sanders TA, Davies IG, Morgan LM, Millward DJ. et al. 2006. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45–70 y: the OPTILIP Study. Am. J. Clin. Nutr. 84:1290–98 [Google Scholar]
  81. Guil‐Guerrero JL. 2007. Stearidonic acid (18:4n‐3): metabolism, nutritional importance, medical uses and natural sources. Eur. J. Lipid Sci. Technol. 109:1226–36 [Google Scholar]
  82. Gutierrez-Gomez Y, Stein AD, Ramakrishnan U, Barraza-Villarreal A, Moreno-Macias H. et al. 2017. Prenatal docosahexaenoic acid supplementation does not affect non-fasting serum lipid and glucose concentrations of offspring at 4 years of age in a follow-up of a randomized controlled clinical trial in Mexico. J. Nutr. 147:242–47 [Google Scholar]
  83. Hallahan B, Ryan T, Hibbeln JR, Murray IT, Glynn S. et al. 2016. Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. Br. J. Psychiatry 209:192–201 [Google Scholar]
  84. Hamam F, Shahidi F. 2006. Synthesis of structured lipids containing medium-chain and omega-3 fatty acids. J. Agric. Food Chem. 54:4390–96 [Google Scholar]
  85. Hansen JB, Olsen JO, Wilsgård L, Lyngmo V, Svensson B. 1993. Comparative effects of prolonged intake of highly purified fish oils as ethyl ester or triglyceride on lipids, haemostasis and platelet function in normolipaemic men. Eur. J. Clin. Nutr. 47:497–507 [Google Scholar]
  86. Harper M, Thom E, Klebanoff MA, Thorp J, Sorokin Y. et al. 2010. Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstet. Gynecol. 115:232–42 [Google Scholar]
  87. Harris WS, Pottala JV, Sands SA, Jones PG. 2007. Comparison of the effects of fish and fish-oil capsules on the n-3 fatty acid content of blood cells and plasma phospholipids. Am. J. Clin. Nutr. 86:1621–25 [Google Scholar]
  88. Hartweg J, Perera R, Montori VM, Dinneen SF, Neil AH, Farmer AJ. 2008. Omega‐3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 1:CD003205 [Google Scholar]
  89. Hauner H, Much D, Vollhardt C, Brunner S, Schmid D. et al. 2012. Effect of reducing the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on infant adipose tissue growth within the first year of life: an open-label randomized controlled trial. Am. J. Clin. Nutr. 95:383–94 [Google Scholar]
  90. Health Can. 2016. The Canadian Nutrient File Ottawa, Ont: Health Can https://www.canada.ca/en/health-canada/services/food-nutrition/healthy-eating/nutrient-data/canadian-nutrient-file-2015-download-files.html
  91. Hibbeln JR. 1998. Fish consumption and major depression. Lancet 351:1213 [Google Scholar]
  92. Hibbeln JR, Davis JM, Steer C, Emmett P, Rogers I. et al. 2007. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369:578–85 [Google Scholar]
  93. Hixson SM, Shukla K, Campbell LG, Hallett RH, Smith SM. et al. 2016. Long-chain omega-3 polyunsaturated fatty acids have developmental effects on the crop pest, the cabbage white butterfly Pieris rapae. PLOS ONE 11:e0152264 [Google Scholar]
  94. Holmes MD, Colditz GA, Hunter DJ, Hankinson SE, Rosner B. et al. 2003. Meat, fish and egg intake and risk of breast cancer. Int. J. Cancer 104:221–27 [Google Scholar]
  95. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM. et al. 2002. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. J. Am. Med. Assoc 287:1815–21 [Google Scholar]
  96. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K. et al. 2006. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese. Circulation 113:195–202 [Google Scholar]
  97. Järvinen R, Knekt P, Rissanen H, Reunanen A. 2006. Intake of fish and long-chain n-3 fatty acids and the risk of coronary heart mortality in men and women. Br. J. Nutr. 95:4824–29 [Google Scholar]
  98. Jazayeri S, Tehrani-Doost M, Keshavarz SA, Hosseini M, Djazayery A. 2008. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust. N. Z. J. Psychiatry 42:192–98 [Google Scholar]
  99. Jensen CL, Voigt RG, Llorente AM, Peters SU, Prager TC. et al. 2010. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J. Pediatr. 157:6900–5 [Google Scholar]
  100. Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. 2015. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am. J. Clin. Nutr. 102:215–21 [Google Scholar]
  101. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly DM. 2008. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr. Neurosci. 11:75–83 [Google Scholar]
  102. Jones PJ, Senanayake VK, Pu S, Jenkins DJ, Connelly PW. et al. 2014. DHA-enriched high–oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial. Am. J. Clin. Nutr. 100:88–97 [Google Scholar]
  103. Judge MP, Harel O, Lammi-Keefe CJ. 2007. A docosahexaenoic acid–functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids 42:117–22 [Google Scholar]
  104. Kalmijn SV, Van Boxtel MPJ, Ocke M, Verschuren WMM, Kromhout D, Launer LJ. 2004. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurol 62:275–80 [Google Scholar]
  105. Kang JX, Leaf A. 1996. The cardiac antiarrhythmic effects of polyunsaturated fatty acid. Lipids 31:S41–44 [Google Scholar]
  106. Kato I, Akhmedkhanov A, Koenig K, Toniolo PG, Shore RE, Riboli E. 1997. Prospective study of diet and female colorectal cancer: the New York University Women's Health Study. Nutr. Cancer 28:276–81 [Google Scholar]
  107. Kelley DS, Adkins Y, Woodhouse LR, Swislocki A, Mackey BE, Siegel D. 2012. Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men. Metab. Syndr. Relat. Disord. 10:32–38 [Google Scholar]
  108. Klebanoff MA, Harper M, Lai Y, Thorp J, Sorokin Y. et al. 2011. Fish consumption, erythrocyte fatty acids, and preterm birth. Obstetr. Gynecol. 117:1071–77 [Google Scholar]
  109. Kling DF, Johnson J, Rooney M, Davidson M. 2011. Omega-3 free fatty acids demonstrate more than 4-fold greater bioavailability for EPA and DHA compared with omega-3-acid ethyl esters in conjunction with a low-fat diet: the ECLIPSE Study. J. Clin. Lipidol. 5:231 [Google Scholar]
  110. Kobayashi N, Barnard RJ, Henning SM, Elashoff D, Reddy ST. et al. 2006. Effect of altering dietary ω-6/ω-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin. Cancer Res. 12:4662–70 [Google Scholar]
  111. Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S. et al. 2016. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage 131:226–38 [Google Scholar]
  112. Kris-Etherton PM, Harris WS, Appel LJ. 2002. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747–57 [Google Scholar]
  113. Kristensen SD, Iversen AB, Schmidt EB. 2001. n-3 polyunsaturated fatty acids and coronary thrombosis. Lipids 36:S79–82 [Google Scholar]
  114. Kröger E, Verreault R, Carmichael PH, Lindsay J, Julien P. et al. 2009. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am. J. Clin. Nutr. 90:184–92 [Google Scholar]
  115. Kromhout D, Giltay EJ, Geleijnse JM. 2010. n–3 fatty acids and cardiovascular events after myocardial infarction. N. Engl. J. Med 2010:2015–26 [Google Scholar]
  116. Laidlaw M, Cockerline CA, Rowe WJ. 2014. A randomized clinical trial to determine the efficacy of manufacturers’ recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction. Lipids Health Dis 13:99 [Google Scholar]
  117. Lalia AZ, Lanza IR. 2016. Insulin-sensitizing effects of omega-3 fatty acids: lost in translation?. Nutrients 8:329 [Google Scholar]
  118. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. 2004. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 79:935–45 [Google Scholar]
  119. Lawson LD, Hughes BG. 1988. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem. Biophys. Res. Commun. 152:328–35 [Google Scholar]
  120. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. 2003. n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am. J. Clin. Nutr. 77:319–25 [Google Scholar]
  121. Lewis EJH. 2013. Omega-3 fatty acid supplementation and cardiovascular disease events. J. Am. Med. Assoc 309:27 [Google Scholar]
  122. Lin PY, Su KP. 2007. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry 68:1056–61 [Google Scholar]
  123. Lopez LB, Kritz-Silverstein D, Barrett-Connor E. 2011. High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study. J. Nutr. Health Aging 15:25–31 [Google Scholar]
  124. Macchia A, Grancelli H, Varini S, Nul D, Laffaye N. et al. 2013. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. J. Am. Coll. Cardiol. 61:463–68 [Google Scholar]
  125. MacLean CH, Mojica WA, Morton SC, Pencharz J, Garland RH. et al. 2004. Effects of omega‐3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis: summary. Evid. Rep. Technol. Assess. (Summ.) 89:1–4 [Google Scholar]
  126. MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM. et al. 2006. Effects of omega-3 fatty acids on cancer risk: a systematic review. J. Am. Med. Assoc 295:403–15 [Google Scholar]
  127. Maki KC, Reeves MS, Farmer M, Griinari M, Berge K. et al. 2009. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr. Res. 29:609–15 [Google Scholar]
  128. Makrides M, Gibson RA, McPhee AJ, Collins CT, Davis PG. et al. 2009. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. J. Am. Med. Assoc 301:175–82 [Google Scholar]
  129. Malcolm CA, McCulloch DL, Montgomery C, Shepherd A, Weaver LT. 2003. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch. Dis. Child. Fetal Neonatal Ed. 88:F383–90 [Google Scholar]
  130. Mamalakis G, Tornaritis M, Kafatos A. 2002. Depression and adipose essential polyunsaturated fatty acids. Prostaglandin Leukot. Essent. Fatty Acids 67:311–18 [Google Scholar]
  131. Martins JG. 2009. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J. Am. Coll. Nutr. 28:525–42 [Google Scholar]
  132. Mathai ML, Soueid M, Chen N, Jayasooriya AP, Sinclair AJ. et al. 2004. Does perinatal ω‐3 polyunsaturated fatty acid deficiency increase appetite signaling?. Obesity 12:1886–94 [Google Scholar]
  133. Mazereeuw G, Herrmann N, Andreazza AC, Scola G, Ma DW, Oh PI, Lanctôt KL. 2017. Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients. Brain Behav. Immun. 60:136–41 [Google Scholar]
  134. McNamara RK, Asch RH, Lindquist DM, Krikorian R. 2017. Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: an update on neuroimaging findings. Prostaglandin Leukot. Essent. Fatty Acids. In press https://doi.org/10.1016/j.plefa.2017.05.001 [Crossref]
  135. Min Y, Djahanbakhch O, Hutchinson J, Bhullar AS, Raveendran M. et al. 2014. Effect of docosahexaenoic acid‐-enriched fish oil supplementation in pregnant women with type 2 diabetes on membrane fatty acids and fetal body composition: double‐blinded randomized placebo‐controlled trial. Diabetic Med 31:1331–40 [Google Scholar]
  136. Mischoulon D, Fava M. 2000. Docosahexanoic acid and ω-3 fatty acids in depression. Psychiatr. Clin. N. Am. 23:785–94 [Google Scholar]
  137. Mischoulon D, Nierenberg AA, Schettler PJ, Kinkead BL, Fehling K. et al. 2015. A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression. J. Clin. Psychiatry 76:54–61 [Google Scholar]
  138. Mocellin MC, de Quadros Camarg C, de Souza Fabre ME, de Moraes Trindade EBS. 2017. Fish oil effects on quality of life, body weight and free fat mass change in gastrointestinal cancer patients undergoing chemotherapy: a triple blind, randomized clinical trial. J. Funct. Foods. 31:113–22 [Google Scholar]
  139. Molloy CS, Stokes S, Makrides M, Collins CT, Anderson PJ, Doyle LW. 2016. Long-term effect of high-dose supplementation with DHA on visual function at school age in children born at <33 wk gestational age: results from a follow-up of a randomized controlled trial. Am. J. Clin. Nutr. 103:268–75 [Google Scholar]
  140. Moorthy B, Jiang W, Zhou G. 2017. Attenuation of polycyclic aromatic hydrocarbon (PAH)-mediated pulmonary carcinogenesis in mice by omega-3-fatty acids. FASEB J 31:Suppl. 11067–64 [Google Scholar]
  141. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN. et al. 2000. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 71:1085–94 [Google Scholar]
  142. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA. et al. 2003. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 60:940–46 [Google Scholar]
  143. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ. et al. 2016. Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133:447–54 [Google Scholar]
  144. Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H. et al. 2013.a Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann. Intern. Med. 158:515–25 [Google Scholar]
  145. Mozaffarian D, Lemaitre RN, King IB, Song X, Spiegelman D. et al. 2011. Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann. Intern. Med. 155:160–70 [Google Scholar]
  146. Mozaffarian D, Wu JH. 2011. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58:2047–67 [Google Scholar]
  147. Mozaffarian D, Wu JH, de Oliveira Otto MC, Sandesara CM, Metcalf RG. et al. 2013.b Fish oil and post-operative atrial fibrillation. J. Am. Coll. Cardiol. 61:2194–96 [Google Scholar]
  148. Mozaffari-Khosravi H, Yassini-Ardakani M, Karamati M, Shariati-Bafghi SE. 2013. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial. Eur. Neuropsychopharmacol. 23:636–44 [Google Scholar]
  149. Mozurkewich EL, Clinton CM, Chilimigras JL, Hamilton SE, Allbaugh LJ. et al. 2013. The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial. Am. J. Obstetr. Gynecol. 208:313–e1 [Google Scholar]
  150. Nakamura Y, Ueshima H, Okamura T, Kadowaki T, Hayakawa T. et al. 2005. Association between fish consumption and all-cause and cause-specific mortality in Japan: NIPPON DATA80, 1980–99. Am. J. Med. 118:239–45 [Google Scholar]
  151. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. 2006. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am. J. Psychiatry 163:61098–100 [Google Scholar]
  152. Neubronner J, Schuchardt JP, Kressel G, Merkel M, Von Schacky C, Hahn A. 2011. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur. J. Clin. Nutr. 65:247–54 [Google Scholar]
  153. Newberry SJ, Chung M, Booth M, Maglione MA, Tang AM. et al. 2016. Omega-3 fatty acids and maternal and child health: an updated systematic review Evid. Rep./Technol. Assess. Number 224 Rep. 16(17)-E003-EF Agency Healthc. Res. Qual Rockville, MD:
  154. Nurk E, Drevon CA, Refsum H, Solvoll K, Vollset SE. et al. 2007. Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. Am. J. Clin. Nutr. 86:1470–78 [Google Scholar]
  155. O'Connell TD, Block RC, Huang SP, Shearer GC. 2016. ω3-Polyunsaturated fatty acids for heart failure: effects of dose on efficacy and novel signaling through free fatty acid receptor 4. J. Mol. Cell. Cardiol. 103:74–92 [Google Scholar]
  156. Oken E, Kleinman KP, Olsen SF, Rich-Edwards JW, Gillman MW. 2004. Associations of seafood and elongated n-3 fatty acid intake with fetal growth and length of gestation: results from a US pregnancy cohort. Am. J. Epidemiol. 160:774–83 [Google Scholar]
  157. Bosch J, Gerstein HC, Dagenais GR, Díaz R. ORIGIN Trial Investig., et al. 2012. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N. Engl. J. Med. 367:309–18 [Google Scholar]
  158. Pacifico L, Bonci E, Di Martino M, Versacci P, Andreoli G. et al. 2015. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 25:734–41 [Google Scholar]
  159. Park MK, Li WQK, Li T, Qureshi AA, Cho E. 2017. Prospective evaluation of fat intake and risk of skin cancer. FASEB J 31:1 Suppl.168–73 [Google Scholar]
  160. Pawlosky RJ, Hibbein JR, Novotny JA, Salem N. 2001. Physiological compartmental analysis of α-linolenic acid metabolism in adult humans. J. Lipid Res. 42:1257–65 [Google Scholar]
  161. Pedrazzoli P, Cereda E, Cappello S, Colombo S, Klersy C. et al. 2017. Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy. J. Clin. Oncol. 35:15 Suppl.10098 [Google Scholar]
  162. Pottala JV, Yaffe K, Robinson JG, Espeland MA, Wallace R, Harris WS. 2014. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study. Neurol 82:435–42 [Google Scholar]
  163. Prener A, Storm HH, Nielsen NH. 1996. Cancer of the male genital tract in circumpolar Inuit. Acta Oncol 35:589–93 [Google Scholar]
  164. Puri BK, Counsell SJ, Richardson AJ, Horrobin DF. 2002. Eicosapentaenoic acid in treatment-resistant depression. Arch. Gen. Psychiatry 59:91–92 [Google Scholar]
  165. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB. et al. 2010. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. J. Am. Med. Assoc 304:1903–11 [Google Scholar]
  166. Raji CA, Erickson KI, Lopez OL, Kuller LH, Gach HM. et al. 2014. Regular fish consumption and age-related brain gray matter loss. Am. J. Prev. Med. 47:444–51 [Google Scholar]
  167. Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Sobajic S. et al. 2007. Effects of n-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren. Fail. 29:321–29 [Google Scholar]
  168. Rauch B, Schiele R, Schneider S, Diller F, Victor N. et al. 2010. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction clinical perspective. Circulation 122:2152–59 [Google Scholar]
  169. Reis GJ, Silverman DI, Boucher TM, Sipperly ME, Horowitz GL. et al. 1990. Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease. Am. J. Cardiol. 66:1171–75 [Google Scholar]
  170. Rhee JJ, Kim E, Buring JE, Kurth T. 2017. Fish consumption, omega-3 fatty acids, and risk of cardiovascular disease. Am. J. Prev. Med. 52:10–19 [Google Scholar]
  171. Rice SM, Hickie IB, Yung AR, Mackinnon A, Berk M. et al. 2016. Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA‐F): a randomized, double‐blind, placebo‐controlled treatment trial. Early Interv. Psychiatry 10:290–99 [Google Scholar]
  172. Risk Prev. Study Collab. Group. 2013. n-3 fatty acids in patients with multiple cardiovascular risk factors. N. Engl. J. Med. 368:1800–8 [Google Scholar]
  173. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. 2012. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. J. Am. Med. Assoc 308:1024–33 [Google Scholar]
  174. Rondanelli M, Giacosa A, Opizzi A, Pelucchi C, La Vecchia C. et al. 2010. Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial. J. Am. Coll. Nutr. 29:55–64 [Google Scholar]
  175. Ross BM, McKenzie I, Glen I, Bennett CPW. 2003. Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr. Neurosci. 6:277–81 [Google Scholar]
  176. Ryan AS, Nelson EB. 2008. Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study. Clin. Pediatr. 47:355–62 [Google Scholar]
  177. Sakai M, Kakutani S, Horikawa C, Tokuda H, Kawashima H. et al. 2012. Arachidonic acid and cancer risk: a systematic review of observational studies. BMC Cancer 12:606 [Google Scholar]
  178. Samieri C, Maillard P, Crivello F, Proust-Lima C, Peuchant E. et al. 2012. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology 79:642–50 [Google Scholar]
  179. Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A. 2011. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations: a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis 10:145 [Google Scholar]
  180. Schulthess G, Lipka G, Compassi S, Boffelli D, Weber FE. et al. 1994. Absorption of monoacylglycerols by small intestinal brush border membrane. Biochemistry 33:4500–8 [Google Scholar]
  181. Schwab U, Lauritzen L, Tholstrup T, Haldorsson TI, Riserus U. et al. 2014. Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food Nutr. Res. 58:25145 [Google Scholar]
  182. Senanayake SPJN, Shahidi F. 2002. Lipase-catalyzed incorporation of docosahexaenoic acid (DHA) into borage oil: optimization using response surface methodology. Food Chem 77:115–23 [Google Scholar]
  183. Senanayake SPJN, Fichtali J. 2006. Marine oils: single cell oil as a sources of nutraceuticals and speciality lipids: processing technologies and application. Nutraceutical and Speciality Lipids and their Co-Products F Shahidi 251–80 Boca Raton, FL: CRC Press [Google Scholar]
  184. Shahidi F. 1998. Functional seafood lipids and proteins. Functional Foods: Biochemical and Processing Aspects G Mazza 381–401 Lancaster, UK: Technomic Publ [Google Scholar]
  185. Shahidi F. 2015. Omega-3 fatty acids and marine oils in cardiovascular and general health: a critical overview of controversies and realities. J. Funct. Foods 19:797–800 [Google Scholar]
  186. Shahidi F, Ambigaipalan P. 2015. Novel functional food ingredients from marine sources. Curr. Opin. Food Sci. 2:123–29 [Google Scholar]
  187. Shahidi F, Ambigaipalan P. 2016. Beverages fortified with omega 3 fatty acids, dietary fiber, minerals and vitamins. Handbook of Functional Beverages and Human Health F Shahidi, C Alsalvar 801–13 Boca Raton, FL: CRC Press [Google Scholar]
  188. Shahidi F, Miraliakbari H. 2004. Omega-3 (n-3) fatty acids in health and disease: part 1—cardiovascular disease and cancer. J. Med. Food 7:387–401 [Google Scholar]
  189. Shahidi F, Miraliakbari H. 2005. Omega-3 (n-3) fatty acids in health and disease: part 2—health effects of omega-3 fatty acids in autoimmune diseases, mental health, and gene expression. J. Med. Food 8:133–48 [Google Scholar]
  190. Shahidi F, Miraliakbari H. 2006. Marine oils: compositional characteristics and health effects. Nutraceutical and Specialty Lipids and their Co-Products F Shahidi 227–50 Boca Raton, FL: CRC Press [Google Scholar]
  191. Shahidi F, Zhong Y. 2015. Fatty acid derivatives of catechins and methods of their use. US Patent No. 9018248
  192. Shahverdi E, Niknam R. 2017. Flaxseed: a good idea for reduction of mastalgia (breast pain) and risk of breast cancer. Focus Sci 3:21–7 [Google Scholar]
  193. Shi Y, Burn P. 2004. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat. Rev. Drug Discov. 3:695–710 [Google Scholar]
  194. Simmer K. 2016. Fish-oil supplementation: the controversy continues. Am. J. Clin. Nutr. 103:1–2 [Google Scholar]
  195. Simon JA, Hodgkins ML, Browner WS, Neuhaus JM, Bernert JT Jr, Hulley SB. 1995. Serum fatty acids and the risk of coronary heart disease. Am. J. Epidemiol. 142:469–76 [Google Scholar]
  196. Simopoulos AP. 2002. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother 56:365–79 [Google Scholar]
  197. Singer P, Richter-Heinrich E. 1991. Stress and fatty liver: possible indications for dietary long-chain n-3 fatty acids. Med. Hypotheses 36:90–94 [Google Scholar]
  198. Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH. et al. 2017. Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association. Circulation 137:e867–84 [Google Scholar]
  199. So WW, Liu WN, Leung KN. 2015. Omega-3 polyunsaturated fatty acids trigger cell cycle arrest and induce apoptosis in human neuroblastoma LA-N-1 cells. Nutrients 7:6956–73 [Google Scholar]
  200. Sorensen LS, Rasmussen HH, Aardestrup IV, Thorlacius-Ussing O, Lindorff-Larsen K. et al. 2014. Rapid incorporation of ω-3 fatty acids into colonic tissue after oral supplementation in patients with colorectal cancer: a randomized, placebo-controlled intervention trial. J. Parenter. Enter. Nutr. 38:617–24 [Google Scholar]
  201. Spencer M, Finlin BS, Unal R, Zhu B, Morris AJ. et al. 2013. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes 62:1709–17 [Google Scholar]
  202. Stephens FB, Mendis B, Shannon CE, Cooper S, Ortori CA. et al. 2014. Fish oil omega-3 fatty acids partially prevent lipid-induced insulin resistance in human skeletal muscle without limiting acylcarnitine accumulation. Clin. Sci. 127:315–22 [Google Scholar]
  203. Streppel MT, Ocké MC, Boshuizen HC, Kok FJ, Kromhout D. 2008. Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur. Heart J. 29:2024–30 [Google Scholar]
  204. Su KP, Lai HC, Yang HT, Su WP, Peng CY. et al. 2014. Omega-3 fatty acids in the prevention of interferon-α-induced depression: results from a randomized, controlled trial. Biol. Psychiatry 76:559–66 [Google Scholar]
  205. Su KP, Shen WW, Huang SY. 2001. Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient. Eur. Neuropsychopharmacol. 11:295–99 [Google Scholar]
  206. Tan Z, Le K, Moghadasian M, Shahidi F. 2012.a Enzymatic synthesis of phytosteryl docosahexaneates and evaluation of their anti-atherogenic effects in apo-E deficient mice. Food Chem 134:2097–104 [Google Scholar]
  207. Tan ZS, Harris WS, Beiser AS, Au R, Himali JJ. et al. 2012.b Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 78:658–64 [Google Scholar]
  208. Tanabe T, Suzuki T, Ogura M, Watanabe Y. 1999. High proportion of docosahexaenoic acid in the lipid of juvenile and young skipjack tuna, Katsuwonuspelamis from the tropical western Pacific. Fish. Sci. 65:806–7 [Google Scholar]
  209. Takezaki T, Inoue M, Kataoka H, Ikeda S, Yoshida M. et al. 2003. Diet and lung cancer risk from a 14-year population-based prospective study in Japan: with special reference to fish consumption. Nutr. Cancer 45:160–67 [Google Scholar]
  210. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG. et al. 2008. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372:1223–30 [Google Scholar]
  211. Terry P, Lichtenstein P, Feychting M, Ahlbom A, Wolk A. 2001. Fatty fish consumption and risk of prostate cancer. Lancet 357:1764–66 [Google Scholar]
  212. Titova OE, Sjögren P, Brooks SJ, Kullberg J, Ax E. et al. 2013. Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly. Age 35:1495–505 [Google Scholar]
  213. Tsitouras PD, Gucciardo F, Salbe AD, Heward C, Harman SM. 2008. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm. Metab. Res. 40:199–205 [Google Scholar]
  214. Uauy R, Valenzuela A. 2000. Marine oils: the health benefits of n-3 fatty acids. Nutrients 16:680–84 [Google Scholar]
  215. Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E. et al. 2011. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 46:37–46 [Google Scholar]
  216. Vakhapova V, Cohen T, Richter Y, Herzog Y, Kam Y, Korczyn AD. 2014. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study. Dement. Geriatr. Cogn. Dis. 38:39–45 [Google Scholar]
  217. Van Blarigan E, Fuchs CS, Niedzwiecki D, Ye X, Zhang S. et al. 2017. Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance). J. Clin. Oncol. 35:585 [Google Scholar]
  218. Vilar-González S, Bloomfield D, Noble M. 2017. Could omega 3 supplements play a role in the prevention of neurocognitive impairment in cancer patients?. Clin. Oncol. 29:e48 [Google Scholar]
  219. Virtanen JK, Siscovick DS, Longstreth WT, Kuller LH, Mozaffarian D. 2008. Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 71:439–46 [Google Scholar]
  220. Visioli F, Risé P, Barassi MC, Marangoni F, Galli C. 2003. Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids. Lipids 38:415–18 [Google Scholar]
  221. Wakil A, Mir M, Mellor DD, Mellor SF, Atkin SL. 2010. The bioavailability of eicosapentaenoic acid from reconstituted triglyceride fish oil is higher than that obtained from the triglyceride and monoglyceride forms. Asia Pac. J. Clin. Nutr. 19:499–505 [Google Scholar]
  222. Walhovd KB, Storsve AB, Westlye LT, Drevon CA, Fjell AM. 2014. Blood markers of fatty acids and vitamin D, cardiovascular measures, body mass index, and physical activity relate to longitudinal cortical thinning in normal aging. Neurobiol. Aging 35:1055–64 [Google Scholar]
  223. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH. ARIC Study Investig 2003. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr. 78:91–98 [Google Scholar]
  224. Werner K, de Gaudry DK, Taylor LA, Keck T, Unger C. et al. 2017. Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil—a randomized controlled double-blind trial. Lipids Health Dis 16:104 [Google Scholar]
  225. White PJ, Arita M, Taguchi R, Kang JX, Marette A. 2010. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes 59:3066–73 [Google Scholar]
  226. Yamagishi K, Iso H, Date C, Fukui M, Wakai K. et al. 2008. Fish, ω-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women: the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) study. J. Am. Coll. Cardiol. 52:988–96 [Google Scholar]
  227. Yang J, Zhu S, Lin G, Song C, He Z. 2017. Vitamin D enhances omega‐3 polyunsaturated fatty acids–induced apoptosis in breast cancer cells. Cell Biol. Int. 41:890–97 [Google Scholar]
  228. Yehuda S, Rabinovitz S, Mostofsky DI. 2005. Essential fatty acids and the brain: from infancy to aging. Neurobiol. Aging 26:98–102 [Google Scholar]
  229. Yehuda S, Rabinovitz-Shenkar S, Carasso RL. 2011. Effects of essential fatty acids in iron deficient and sleep-disturbed attention deficit hyperactivity disorder (ADHD) children. Eur. J. Clin. Nutr. 65:1167–69 [Google Scholar]
  230. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y. et al. 2007. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369:1090–98 [Google Scholar]
  231. Yu FL, Greenlaw R, Fang Q, Bender W, Yamaguchi K. et al. 2004. Studies on the chemopreventive potentials of vegetable oils and unsaturated fatty acids against breast cancer carcinogenesis at initiation. Eur. J. Cancer Prev. 13:239–48 [Google Scholar]
  232. Yu J, Liu L, Zhang Y, Wei J, Yang F. 2017. Effects of omega-3 fatty acids on patients undergoing surgery for gastrointestinal malignancy: a systematic review and meta-analysis. BMC Cancer 17:271 [Google Scholar]
  233. Yuan JM, Ross RK, Gao YT, Mimi CY. 2001. Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am. J. Epidemiol. 154:809–16 [Google Scholar]
  234. Zheng JS, Hu XJ, Zhao YM, Yang J, Li D. 2013. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 346:f3706 [Google Scholar]
  235. Zhong Y, Chiou YS, Pan MH, Ho CT, Shahidi F. 2012. Protective effects of epigallocatechin gallate (EGCG) derivatives on azoxymethane-induced colonic carcinogenesis in mice. J. Funct. Foods 4:323–30 [Google Scholar]
  236. Zhong Y, Shahidi F. 2011. Lipophilized epigallocatechin gallate (EGCG) derivatives as novel antioxidants. J. Agric. Food Chem. 59:6526–33 [Google Scholar]
/content/journals/10.1146/annurev-food-111317-095850
Loading
/content/journals/10.1146/annurev-food-111317-095850
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error